New "From Lab to Market" Episode: From Research to Founding a Company

How does years of research become a start-up? And what does it take to develop a scientific idea into a therapy that genuinely helps patients? In the second episode of the "From Lab to Market" podcast, Felina Kallbach speaks with David Rudolph of NanoDrug Delivery GmbH about the path from research to founding a company, and why these two worlds are often more different than one might expect.

NanoDrug Delivery is developing a novel nanoparticle technology designed to deliver active substances more precisely to their target site in the body. It's an approach with the potential to improve the effectiveness of therapies and open up new possibilities, not least in cancer treatment.

The conversation isn't only about technology, though. It's also about the people behind it: the interdisciplinary collaboration between chemistry and medicine, the challenges of running a biotech start-up, and the question of what keeps you going when the road is long and demanding. One thought from David Rudolph stayed with us in particular: his greatest motivation is the prospect of one day making a real difference in patients' lives through his work. Listen to the episode here.